AB-CHMINACA

AB-CHMINACA

produktbeskrivelse
AB-CHMINACA for sale
AB-FUBINACA is an indazole-based synthetic cannabinoid (CB) with 10-fold higher affinity relating to the main CB1 receptor (Ki = 0.9 nM) in contrast to JWH 018 .

AB-FUBINACA was initially synthesized by Pfizer, Inc. as an effective powerful CB1 receptor modulator for possible therapeutic usage, however not too long ago had been discovered together with AB-PINACA in prohibited herbal products.

AB-CHMINACA is structurally relevant to AB-FUBINACA which includes a cyclohexyl group replaced for the 4-fluorophenyl group. The physical and toxicological attributes associated with the substance haven’t been identified. The product was created for research and forensic purposes.

This fine research chemical in our laboratory. We can ensure you that when you order from us you will get a high purity research chemical for your research purspose.

This research chemical is not intended for human consumption. This cannabinoid ship direct from our lab to any country in the world.

Dosering
Forutsetter ingen toleranse

Terskelen

Vanlige 1 – 3 mg

Sterk 4 – 5 mg

Tung > 5 mg

Varighet
Total 1 – 2 timer
Utbruddet 0 – 20 minutter
Topp 30 – 60 minutter
Offset 10 – 20 minutter
Etterglød 15 – 30 minutter

AB-CHMINACA er en indazole-basert syntetisk cannabinoid. Det er en potent agonist av CB₁ reseptor og CB₂ reseptor og fullt ut erstatter Δ⁹-THC i rotte diskriminering studier, samtidig som 16x mer potent

AB-CHMINACA er en indazole-basert syntetisk cannabinoid. Det er en potent agonist av CB₁ reseptor og CB₂ reseptor og fullt ut erstatter Δ⁹-THC i rotte diskriminering studier, samtidig som 16x mer potent

AB-CHMINACA is structurally relevant to AB-FUBINACA which includes a cyclohexyl group replaced for the 4-fluorophenyl group. The physical and toxicological attributes associated with the substance haven’t been identified. The product was created for research and forensic purposes.